Cryosite Limited (CTE.AX)
Cryosite Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in South Granville, NSW, AU. The stock last traded at $1.25, up 0.00% on the session, giving a market capitalisation of $61.0M. Its beta of 0.15 implies it has historically moved less than the broad market.
Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions. Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation. The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.
Cryosite Limited is most often compared with the following Healthcare names: